
Corcept Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update
MENLO PARK, CA -- (Marketwired) -- 08/02/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) Second quarter revenue of $19.7 million, a 65 percent increase from the second quarter of 2015 Second quarter GAAP net income of $0.01 per share, compared to a …